We followed up on this analysis, aiming to identify genes that were not previously GWS (based on our data) in AD (0.05 < Pgene-AD > 2.60 × 10−6) or lipids (0.05 < Pgenes-lipids > 2.60 × 10−6) or CAD traits (0.05 < Pgene-CAD-traits > 2.60 × 10−6) but reached the status following FCP analysis (PFCP < 2.60 × 10−6). The gene discussed is CAD; the disease is Alzheimer disease.